Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.525p on 07-10-2025 at 18:40:08
Change 0.00p 0%
Buy 0.55p
Sell 0.50p
Last Trade: Sell 3,663.00 at 0.50p
Day's Volume: 333,306
Last Close: 0.525p
Open: 0.525p
ISIN: GB00BLH13C52
Day's Range 0.525p - 0.525p
52wk Range: 0.39p - 2.25p
Market Capitalisation: £1.97m
VWAP: 0.532699p
Shares in Issue: 374.35m

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 3,663 0.50p Ordinary
15:48:46 - 07-Oct-25
Sell* 26 0.50p Ordinary
15:23:45 - 07-Oct-25
Sell* 554 0.50p Ordinary
15:23:23 - 07-Oct-25
Buy* 309 0.55p Ordinary
14:56:46 - 07-Oct-25
Sell* 12,104 0.50p Ordinary
13:58:13 - 07-Oct-25
Buy* 181 0.55p Ordinary
13:14:53 - 07-Oct-25
Buy* 82,604 0.5375p Ordinary
12:54:34 - 07-Oct-25
Sell* 20,652 0.50p Ordinary
11:59:47 - 07-Oct-25
Sell* 5,832 0.50p Ordinary
09:07:52 - 07-Oct-25
Buy* 23,000 0.5375p Ordinary
09:03:01 - 07-Oct-25
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
7th Oct 2025 (Tue) 0.525 0.525 0.525 0.525 333,306
6th Oct 2025 (Mon) 0.525 0.525 0.525 0.525 103,922
3rd Oct 2025 (Fri) 0.525 0.525 0.525 0.525 992,407
2nd Oct 2025 (Thu) 0.525 0.525 0.525 0.525 979,590
1st Oct 2025 (Wed) 0.575 0.575 0.525 0.525 2,539,956
30th Sep 2025 (Tue) 0.575 0.575 0.575 0.575 2,567,105
29th Sep 2025 (Mon) 0.625 0.625 0.55 0.575 2,030,492
26th Sep 2025 (Fri) 0.625 0.625 0.625 0.625 87,295
25th Sep 2025 (Thu) 0.625 0.625 0.625 0.625 519,811
24th Sep 2025 (Wed) 0.625 0.625 0.625 0.625 170,789
23rd Sep 2025 (Tue) 0.625 0.625 0.625 0.625 659,369
22nd Sep 2025 (Mon) 0.625 0.625 0.625 0.625 490,340
19th Sep 2025 (Fri) 0.675 0.675 0.625 0.625 1,945,516
18th Sep 2025 (Thu) 0.675 0.70 0.675 0.675 5,774,832
17th Sep 2025 (Wed) 0.675 0.675 0.675 0.675 928,560
16th Sep 2025 (Tue) 0.675 0.675 0.675 0.675 519,705
15th Sep 2025 (Mon) 0.75 0.75 0.675 0.675 2,054,073
12th Sep 2025 (Fri) 0.75 0.75 0.75 0.75 1,002,231
11th Sep 2025 (Thu) 0.75 0.75 0.75 0.75 7,113
10th Sep 2025 (Wed) 0.75 0.75 0.75 0.75 2,110,985
9th Sep 2025 (Tue) 0.75 0.75 0.75 0.75 1,244,912
8th Sep 2025 (Mon) 0.70 0.75 0.70 0.75 1,262,927
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
29th Sep 2025 7:00 am RNS Half-year Report
18th Sep 2025 7:00 am RNS Inaphaea Commercial Update
1st Sep 2025 7:00 am RNS Cytolytix Commercial update
26th Aug 2025 7:00 am RNS Commercial update
7th Aug 2025 10:51 am RNS ValiRx Awarded Grant from Open University
5th Aug 2025 9:53 am RNS Update on Evaluation Agreement with Stingray Bio
4th Aug 2025 7:00 am RNS Licensing Agreement with Dominion Biotech Ltd
29th Jul 2025 7:00 am RNS Collaboration Agreement with Voxcell BioInnovation
30th Jun 2025 3:48 pm RNS Result of AGM
20th Jun 2025 7:00 am RNS Ambrose Exercise Option on VAL401
See more ValiRx regulatory news

ValiRx (VAL) Share News

EARNINGS: ValiRx says trading "challenging"; Mindflair swings to loss

29th Sep 2025 12:56

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: Wellnex makes Storelink its New Zealand distributor

18th Sep 2025 22:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

ValiRx's Cytolytix gets EU patent allowance for nanoparticles

1st Sep 2025 14:02

(Alliance News) - ValiRx PLC on Monday said it has received a notice of allowance from the European Patent Office for "nanoparticle for anti-cancer peptides and uses thereof", a key patent application for majority-owned subsidiary Cytolytix Ltd. Read More

AIM WINNERS & LOSERS: Mkango interim loss widens on China restrictions

1st Sep 2025 10:35

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

ValiRx establishes new subsidiary for prostate cancer assets

26th Aug 2025 14:23

(Alliance News) - ValiRx PLC on Tuesday announced its establishment of a new wholly-owned subsidiary, and plans to file new patents for Val201. Read More

See more ValiRx news
FTSE 100 Latest
Value9,483.58
Change4.44

Login to your account

Forgot Password?

Not Registered